Actionable news
All posts from Actionable news
Actionable news in CUR: NEURALSTEM Inc,

UPDATE: Neuralstem stock plummets 61% on news of mid-stage clinical trial miss

Neuralstem Inc. CUR, +1.64% shares plummeted 61% in premarket trade Tuesday on news of a mid-stage clinical trial miss for its major depressive disorder drug. The drug, NSI-189, did not meet its primary endpoint of a statistically significant reduction in...